Microbial Mogroside Biosynthesis for High-Purity Sweetener Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The limited availability and purification difficulties of mogrosides from the Siraitia grosvenorii plant hinder their commercialization as a high-intensity sweetener due to low plant yields, cultivation requirements, and off-flavors in extracted products.
Innovation Solution
A recombinant microbial process using engineered microbial strains expressing heterologous enzyme pathways to convert isopentenyl pyrophosphate and dimethylallyl pyrophosphate into mogrol and mogrol glycosides, involving enzymes such as farnesyl diphosphate synthase, squalene synthase, and uridine diphosphate-dependent glycosyltransferases to produce mogrol glycosides like Mog.V.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If mogrosides are extracted from Siraitia grosvenorii fruit, then sweetener product is obtained, but the yield is limited due to low plant yields and cultivation requirements
Solution Approach 1:
The patent creates a recombinant microbial system that copies the mogroside biosynthetic pathway from the plant. By transferring the genetic information (genes encoding enzymes like UGTs, CYP450s, and other pathway enzymes) into microbial hosts such as E. coli or yeast, the system replicates the plant's ability to produce mogrosides without requiring actual plant cultivation, thereby overcoming yield limitations and cultivation constraints
Solution Approach 2:
The patent uses recombinant microorganisms as intermediary systems to produce mogrosides. These microbial hosts serve as mediators that convert simple substrates (like glucose or other carbon sources) into complex mogroside molecules through the expressed heterologous enzyme pathways, eliminating the need for direct plant extraction while maintaining product authenticity
2Manufacturing precision
If mogroside extract is produced from plant material, then sweetener is obtained, but purification is difficult and off-flavors remain
Solution Approach 1:
The patent extracts only the essential biosynthetic pathway genes from the plant and transfers them into microbial hosts, leaving behind all the problematic plant matrix components that cause off-flavors and purification difficulties. The microbial system produces only the desired mogroside molecules without co-extracting plant proteins, fibers, or other contaminants
Solution Approach 2:
The patent employs transient microbial cultures that are grown, harvested, and discarded after a single production cycle. These short-lived microbial systems produce high-purity mogrosides that can be easily separated from cell debris, avoiding the persistent contamination issues associated with plant extract purification while being cost-effective for industrial production
3Manufacturing precision
If recombinant microbial process is used to produce mogrol glycosides, then high-purity product is obtained, but complex enzyme pathways must be engineered
Solution Approach 1:
The patent divides the complex mogroside biosynthetic pathway into discrete functional modules, each encoded by specific genes (such as UGT genes for glycosylation, CYP450 genes for oxidation, and other pathway-specific enzymes). These modular gene clusters can be independently optimized, assembled, and expressed in the microbial host, making the complex pathway manageable and engineerable while achieving high product purity
Solution Approach 2:
The patent employs universal microbial expression systems (such as E. coli or yeast with standardized genetic tools) that can express multiple different enzyme pathways simultaneously. This universal platform allows the same host to produce various mogroside types (Mog.V, Mog.VI, etc.) by simply changing the inserted gene组合, reducing overall system complexity despite the intricate biosynthetic requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of high-purity mogrol glycosides, overcoming yield limitations and purification challenges, facilitating their use as a commercial sweetener with improved solubility and reduced off-flavors.
Implementation Method 1
The heterologous enzyme pathway comprises a farnesyl diphosphate synthase (FPPS) and a squalene synthase (SQS), which are recombinantly expressed
Implementation Method 2
The host cell produces MEP or MVA pathway products, which act as substrates for the heterologous enzyme pathway
Data Source
AI summary
The present invention provides host cells and methods for making mogrol glycosides, including Mogroside V (Mog.V), Mogroside VI (Mog.VI), Iso-Mogroside V (Isomog.V), siamenoside, and glycosylation products that are minor products in Siraitia grosvenorii. The invention provides engineered enzymes and engineered host cells for producing mogrol glycosylation products, such as Mog.V, Mog.VI, and Isomog.V, at high purity and/or yield. The present technology further provides methods of making products containing mogrol glycosides, such as Mog.V, Mog.VI, and Isomog.V, including food products, beverages, oral care products, sweeteners, and flavoring products.